![]() |
市场调查报告书
商品编码
1817975
睡眠和放鬆营养市场预测至 2032 年:按产品类型、剂型、类型、应用、最终用户和地区进行的全球分析Sleep & Relaxation Nutrition Market Forecasts to 2032 - Global Analysis By Product Type (Melatonin, Herbal Extracts, Magnesium, L-theanine, Vitamins & Minerals, and Dietary Fiber), Dosage Form, Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球睡眠和放鬆营养市场预计在 2025 年达到 52 亿美元,到 2032 年将达到 75 亿美元,预测期内的复合年增长率为 5.2%。
睡眠和放鬆营养包括旨在促进安稳睡眠週期和减轻压力的食品、饮料和补充剂。这些产品通常含有褪黑激素、L-茶氨酸和镁等生物活性成分,以及洋甘菊和缬草根等草本萃取物。它们有助于调节昼夜节律、镇静神经活动并降低皮质醇水平。睡前或压力大时服用,有助于自然放鬆机制。这类产品将功能性营养科学与生活方式需求结合,以改善睡眠品质和情绪平衡。
据美国疾病管制与预防中心称,超过三分之一的美国成年人睡眠不足,这推动了对非药物解决方案的需求,例如机能饮料和含有褪黑激素和镁的补充剂。
压力增加和睡眠障碍
在全球范围内,压力、焦虑和睡眠相关障碍的盛行率不断上升,是影响睡眠和放鬆营养市场的主要驱动因素。日益增加的工作压力、生活方式的改变以及数位疲劳都会导致睡眠障碍,从而刺激了消费者对天然疗法和功能性营养产品的需求。随着消费者对睡眠不足相关健康风险的认识不断提高,他们开始转向褪黑激素、草本混合物和功能性补充剂,从而推动了已开发地区和新兴地区的持续成长。
缺乏普遍接受的疗效标准
儘管睡眠和放鬆补充剂的应用日益广泛,但由于缺乏标准化的法律规范或功效标准,阻碍了其广泛普及。全球各地不同的法规对产品核可和市场拓展构成了障碍。由于临床证据不一致,医疗保健提供者和消费者依然心存疑虑。缺乏统一的品质和剂量指南限制了产品的可信度,并限制了新参与企业的进入。因此,功效检验的不确定性和消费者信任问题在一定程度上限制了市场的成长。
职场健康和企业健康计划的增长
企业健康计画越来越多地将睡眠和压力管理解决方案纳入员工社会福利,这带来了巨大的成长机会。雇主意识到疲劳和压力会导致生产力下降,这促使他们投资营养补充品来放鬆身心、恢復活力。在职场健康计画的推动下,企业正在与补充剂品牌合作,提供天然的助眠产品。随着心理健康宣传活动的日益普及,职场主导的需求可能会推动市场渗透和品牌知名度的提升。
来自药物助眠剂的竞争
睡眠营养领域面临来自传统药物助眠剂的竞争,这些药物通常用于快速缓解症状。儘管对天然解决方案的需求日益增长,但许多消费者仍然依赖成熟的药物,因为它们具有强大的医学背景。在积极的药品行销和非处方药的推动下,膳食补充剂难以将自己定位为有效的替代品。除非膳食补充剂品牌加强临床检验并进行有针对性的差异化,否则这种威胁可能会限制天然睡眠解决方案的快速普及。
新冠疫情(COVID-19)导致压力、焦虑和睡眠週期紊乱等问题普遍存在,加速了对睡眠和放鬆营养产品的需求。封锁、远距办公和不确定性增强了消费者的健康意识,促使消费者寻求自然疗法。褪黑素、草本茶和放鬆补充剂的线上销售飙升,电商成为重要的分销管道。然而,供应链中断和原材料短缺暂时限制了生产。整体而言,疫情起到了催化剂的作用,使睡眠补充剂成为人们日常健康习惯的一部分。
褪黑激素市场预计将在预测期内占据最大份额
由于消费者认知度高,且在调节睡眠-觉醒週期方面的有效性已得到证实,预计褪黑激素细分市场将在预测期内占据最大市场份额。褪黑激素在膳食补充剂和机能性食品中被广泛采用,在全球范围内需求旺盛。从软糖到胶囊等多种剂型,褪黑激素的普及性进一步提升了其可近性。此外,消费者对褪黑激素作为一种安全天然的荷尔蒙的良好认知,使其成为该品类扩张的关键驱动力。
平板电脑市场预计将在预测期内以最高复合年增长率成长
预计在预测期内,片剂细分市场将实现最高成长率,这得益于便利性、剂量准确性以及日益增长的消费者偏好。片剂因其便携性、较长的保质期和价格实惠的特点,在全球市场上是一种颇受欢迎的给药方式。製造商正在创新片剂,将植物成分和维生素结合,打造多功能褪黑激素混合物。受药局和电商平台需求成长的推动,片剂预计将成为市场上复合年增长率最快的产品。
预计亚太地区将在预测期内占据最大的市场份额,这得益于消费者对压力管理意识的不断增强以及可支配收入的不断增长。草药和功能性放鬆疗法在中国、印度和日本等国家已成为一种传统,这与补充剂的普及同步。都市化进程的加速和工作时间的延长进一步推动了对睡眠营养品的需求。零售分销的快速成长和电子商务的渗透使亚太地区成为关键的区域市场。
在预测期内,由于人们健康意识的增强、压力的普遍存在以及对天然睡眠补充剂日益增长的兴趣,北美预计将实现最高的复合年增长率。大型营养补充品製造商的强大影响力,加上积极的行销宣传活动,正在推动其普及。美国在该地区处于领先地位,这得益于与生活方式相关的睡眠问题以及褪黑激素和植物混合物的广泛接受。不断增加的研发投入和创新产品的推出,进一步推动了该地区的快速成长轨迹。
According to Stratistics MRC, the Global Sleep & Relaxation Nutrition Market is accounted for $5.2 billion in 2025 and is expected to reach $7.5 billion by 2032 growing at a CAGR of 5.2% during the forecast period. Sleep and relaxation nutrition encompasses foods, beverages, and supplements designed to promote restful sleep cycles and alleviate stress. These products often feature bioactives such as melatonin, L-theanine, magnesium, or herbal extracts like chamomile and valerian root. They work by regulating circadian rhythms, calming neural activity, or reducing cortisol levels. Consumed before bedtime or during stressful periods, they support natural relaxation mechanisms. This category integrates functional nutrition science with lifestyle needs to improve sleep quality and emotional balance.
According to the CDC, over 1 in 3 US adults don't get enough sleep, fueling demand for non-pharmaceutical solutions like functional beverages and supplements containing melatonin or magnesium.
Rising prevalence of stress and sleep disorders
The growing global incidence of stress, anxiety, and sleep-related disorders is a primary driver shaping the sleep and relaxation nutrition market. Increasing work pressure, changing lifestyles, and digital fatigue are contributing to sleep disturbances, spurring consumer demand for natural remedies and functional nutrition products. Spurred by rising awareness of the health risks associated with poor sleep, consumers are shifting toward melatonin, herbal blends, and functional supplements, fueling consistent growth across both developed and emerging regions.
Lack of universally accepted efficacy standards
Despite growing adoption, the absence of standardized regulatory frameworks and efficacy benchmarks for sleep and relaxation supplements hinders widespread acceptance. Differing global regulations create barriers for product approvals and market expansion. Fueled by inconsistent clinical evidence, skepticism remains among healthcare providers and consumers. This lack of uniform quality and dosage guidelines limits product credibility and restricts entry for new players. Consequently, market growth is partially restrained by uncertainty over efficacy validation and consumer trust issues.
Growth in workplace wellness and corporate health plans
Corporate wellness programs are increasingly incorporating sleep and stress-management solutions into employee health benefits, providing a significant growth opportunity. Employers are recognizing the productivity losses linked to fatigue and stress, prompting investments in nutritional aids for relaxation and recovery. Spurred by workplace wellness initiatives, companies are partnering with supplement brands to provide natural sleep enhancers. With rising adoption of mental health awareness campaigns, workplace-driven demand is likely to bolster market penetration and brand visibility.
Competition from pharmaceutical sleep aids
The sleep nutrition sector faces competition from conventional pharmaceutical sleep aids, which are often prescribed for faster relief. Despite growing demand for natural solutions, many consumers still rely on established medications due to strong medical endorsement. Fueled by aggressive pharmaceutical marketing and easy availability of over-the-counter options, nutraceuticals struggle to position themselves as effective alternatives. This threat may limit rapid adoption of natural sleep solutions unless nutraceutical brands strengthen clinical validation and targeted differentiation.
The COVID-19 pandemic accelerated demand for sleep and relaxation nutrition products as stress, anxiety, and disrupted sleep cycles became widespread. Lockdowns, remote work, and uncertainty fueled heightened health consciousness, pushing consumers toward natural solutions. Online sales of melatonin, herbal teas, and relaxation supplements surged, with e-commerce becoming a critical distribution channel. However, supply chain disruptions and ingredient shortages temporarily constrained production. Overall, the pandemic acted as a catalyst, normalizing sleep-support supplements as part of wellness routines.
The melatonin segment is expected to be the largest during the forecast period
The melatonin segment is expected to account for the largest market share during the forecast period, resulting from strong consumer awareness and proven efficacy in regulating sleep-wake cycles. Fueled by broad adoption across both dietary supplements and functional food products, melatonin enjoys high demand globally. Its availability in diverse forms, from gummies to capsules, further enhances accessibility. Additionally, favorable consumer perception as a safe and natural hormone positions melatonin as the dominant driver of category expansion.
The tablets segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the tablets segment is predicted to witness the highest growth rate, propelled by convenience, dosage accuracy, and widespread consumer preference. Tablets offer portability, longer shelf life, and affordability, making them a popular delivery format across global markets. Manufacturers are innovating with multi-functional blends in tablet form, combining melatonin with botanicals and vitamins. Spurred by growing demand in pharmacies and e-commerce platforms, tablets are set to register the fastest CAGR in the market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to increasing consumer awareness of stress management and rising disposable incomes. Traditional practices in countries like China, India, and Japan already support herbal and functional remedies for relaxation, which aligns with supplement adoption. Expanding urbanization and long working hours further heighten demand for sleep-support nutrition. With rapid growth in retail distribution and e-commerce penetration, Asia Pacific remains the leading regional market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with rising health-conscious consumers, high stress prevalence, and growing interest in natural sleep aids. Strong presence of leading nutraceutical players, coupled with aggressive marketing campaigns, is propelling adoption. The U.S. leads the region, driven by lifestyle-driven sleep issues and widespread acceptance of melatonin and botanical blends. Enhanced R&D investments and innovative product launches further boost the region's rapid growth trajectory.
Key players in the market
Some of the key players in Sleep & Relaxation Nutrition Market include Danone S.A., Unilever PLC, The Coca-Cola Company, General Mills Inc., Kellogg Company, Mondelez International Inc., Abbott Laboratories, Amway Corporation, Herbalife Nutrition Ltd., Archer Daniels Midland Company, Kerry Group PLC, DSM-Firmenich AG, Glanbia PLC, Swisse Wellness, Suntory Holdings Limited, and Yakult Honsha Co. Ltd.
In Sep 2025, Danone S.A. introduced the new 'Good Night' yogurt drink, a dairy-based functional beverage enriched with melatonin, magnesium, and L-theanine specifically designed to support the body's natural sleep-wake cycle.
In Aug 2025, Unilever PLC (OLLY) launched its 'Sleep Berry' gummy supplement line, featuring a proprietary blend of adaptogens like ashwagandha and rhodiola to help the body manage stress and promote relaxation before bed.
In July 2025, The Coca-Cola Company announced the launch of 'Peaceful Drop', a still water beverage under the Smartwater brand infused with calming botanicals like lavender and chamomile, targeting consumers seeking non-carbonated, functional relaxation drinks.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.